Scaling up and expanding Right Care in the Right Place - immunoglobulins

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 838002828

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2021
  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)
  • Principal Investigator

    Drs. RAAL van Ras
  • Research Location

    N/A
  • Lead Research Institution

    Alcura apotheek
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Establishment of the care pathway for immunoglobulin treatment in the home environment by Alcura. Due to JZOJP, reinforced by COVID, chronic medication treatments are increasingly given at home instead of in the hospital. This offers more comfort and quality for the patient. In collaboration with hospitals, Alcura has years of experience in supplying and administering specialist medication at home. This was often low-complex medication, for which a nurse provided administration or instructions. Highly complex care pathways, such as immunoglobulins, require new services, including infusion care, including infusion pumps and guidance of patients from infusion to subcutaneous administration. By motivating and training patients to administer their own medication, we promote self-management and the patient becomes independent of nursing care, so that Alcura can help other patients who need it. In this way we combine efficiency with personalized care.